Skp2 is oncogenic and overexpressed in human cancers

Matthias Gstaiger, Richard Jordan, Megan Lim, Charles Catzavelos, Jürgen Mestan, Joyce M Slingerland, Wilhelm Krek

Research output: Contribution to journalArticle

398 Citations (Scopus)

Abstract

Skp2 is a member of the F-box family of substrate-recognition subunits of SCF ubiquitin-protein ligase complexes that has been implicated in the ubiquitin-mediated degradation of several key regulators of mammalian G1 progression, including the cyclindependent kinase inhibitor p27, a dosage-dependent tumor suppressor protein. In this study, we examined Skp2 and p27 protein expression by immunohistochemistry in normal oral epithelium and in different stages of malignant oral cancer progression, including dysplasia and oral squamous cell carcinoma. We found that increased levels of Skp2 protein are associated with reduced p27 in a subset of oral epithelial dysplasias and carcinomas compared with normal epithelial controls. Tumors with high Skp2 (>20% positive cells) expression invariably showed reduced or absent p27 and tumors with high p27 (>20% positive cells) expression rarely showed Skp2 positivity. Increased Skp2 protein levels were not always correlated with increased cell proliferation (assayed by Ki-67 staining), suggesting that alterations of Skp2 may contribute to the malignant phenotype without affecting proliferation. Skp2 protein overexpression may lead to accelerated p27 proteolysis and contribute to malignant progression from dysplasia to oral epithelial carcinoma. Moreover, we also demonstrate that Skp2 has oncogenic potential by showing that Skp2 cooperates with H-RasG12V to malignantly transform primary rodent fibroblasts as scored by colony formation in soft agar and tumor formation in nude mice. The observations that Skp2 can mediate transformation and is up-regulated during oral epithelial carcinogenesis support a role for Skp2 as a protooncogene in human tumors.

Original languageEnglish
Pages (from-to)5043-5048
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume98
Issue number9
DOIs
StatePublished - Apr 24 2001
Externally publishedYes

Fingerprint

S-Phase Kinase-Associated Proteins
Ubiquitin-Protein Ligase Complexes
Neoplasms
SKP Cullin F-Box Protein Ligases
Carcinoma
Tumor Suppressor Proteins
Mouth Neoplasms
Ubiquitin
Nude Mice
Proteolysis
Agar
Squamous Cell Carcinoma
Rodentia
Carcinogenesis
Phosphotransferases
Epithelium
Fibroblasts
Immunohistochemistry
Cell Proliferation
Staining and Labeling

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

Skp2 is oncogenic and overexpressed in human cancers. / Gstaiger, Matthias; Jordan, Richard; Lim, Megan; Catzavelos, Charles; Mestan, Jürgen; Slingerland, Joyce M; Krek, Wilhelm.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 98, No. 9, 24.04.2001, p. 5043-5048.

Research output: Contribution to journalArticle

Gstaiger, Matthias ; Jordan, Richard ; Lim, Megan ; Catzavelos, Charles ; Mestan, Jürgen ; Slingerland, Joyce M ; Krek, Wilhelm. / Skp2 is oncogenic and overexpressed in human cancers. In: Proceedings of the National Academy of Sciences of the United States of America. 2001 ; Vol. 98, No. 9. pp. 5043-5048.
@article{3eae6cd06e934a2197a0785d7d189cc0,
title = "Skp2 is oncogenic and overexpressed in human cancers",
abstract = "Skp2 is a member of the F-box family of substrate-recognition subunits of SCF ubiquitin-protein ligase complexes that has been implicated in the ubiquitin-mediated degradation of several key regulators of mammalian G1 progression, including the cyclindependent kinase inhibitor p27, a dosage-dependent tumor suppressor protein. In this study, we examined Skp2 and p27 protein expression by immunohistochemistry in normal oral epithelium and in different stages of malignant oral cancer progression, including dysplasia and oral squamous cell carcinoma. We found that increased levels of Skp2 protein are associated with reduced p27 in a subset of oral epithelial dysplasias and carcinomas compared with normal epithelial controls. Tumors with high Skp2 (>20{\%} positive cells) expression invariably showed reduced or absent p27 and tumors with high p27 (>20{\%} positive cells) expression rarely showed Skp2 positivity. Increased Skp2 protein levels were not always correlated with increased cell proliferation (assayed by Ki-67 staining), suggesting that alterations of Skp2 may contribute to the malignant phenotype without affecting proliferation. Skp2 protein overexpression may lead to accelerated p27 proteolysis and contribute to malignant progression from dysplasia to oral epithelial carcinoma. Moreover, we also demonstrate that Skp2 has oncogenic potential by showing that Skp2 cooperates with H-RasG12V to malignantly transform primary rodent fibroblasts as scored by colony formation in soft agar and tumor formation in nude mice. The observations that Skp2 can mediate transformation and is up-regulated during oral epithelial carcinogenesis support a role for Skp2 as a protooncogene in human tumors.",
author = "Matthias Gstaiger and Richard Jordan and Megan Lim and Charles Catzavelos and J{\"u}rgen Mestan and Slingerland, {Joyce M} and Wilhelm Krek",
year = "2001",
month = "4",
day = "24",
doi = "10.1073/pnas.081474898",
language = "English",
volume = "98",
pages = "5043--5048",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "9",

}

TY - JOUR

T1 - Skp2 is oncogenic and overexpressed in human cancers

AU - Gstaiger, Matthias

AU - Jordan, Richard

AU - Lim, Megan

AU - Catzavelos, Charles

AU - Mestan, Jürgen

AU - Slingerland, Joyce M

AU - Krek, Wilhelm

PY - 2001/4/24

Y1 - 2001/4/24

N2 - Skp2 is a member of the F-box family of substrate-recognition subunits of SCF ubiquitin-protein ligase complexes that has been implicated in the ubiquitin-mediated degradation of several key regulators of mammalian G1 progression, including the cyclindependent kinase inhibitor p27, a dosage-dependent tumor suppressor protein. In this study, we examined Skp2 and p27 protein expression by immunohistochemistry in normal oral epithelium and in different stages of malignant oral cancer progression, including dysplasia and oral squamous cell carcinoma. We found that increased levels of Skp2 protein are associated with reduced p27 in a subset of oral epithelial dysplasias and carcinomas compared with normal epithelial controls. Tumors with high Skp2 (>20% positive cells) expression invariably showed reduced or absent p27 and tumors with high p27 (>20% positive cells) expression rarely showed Skp2 positivity. Increased Skp2 protein levels were not always correlated with increased cell proliferation (assayed by Ki-67 staining), suggesting that alterations of Skp2 may contribute to the malignant phenotype without affecting proliferation. Skp2 protein overexpression may lead to accelerated p27 proteolysis and contribute to malignant progression from dysplasia to oral epithelial carcinoma. Moreover, we also demonstrate that Skp2 has oncogenic potential by showing that Skp2 cooperates with H-RasG12V to malignantly transform primary rodent fibroblasts as scored by colony formation in soft agar and tumor formation in nude mice. The observations that Skp2 can mediate transformation and is up-regulated during oral epithelial carcinogenesis support a role for Skp2 as a protooncogene in human tumors.

AB - Skp2 is a member of the F-box family of substrate-recognition subunits of SCF ubiquitin-protein ligase complexes that has been implicated in the ubiquitin-mediated degradation of several key regulators of mammalian G1 progression, including the cyclindependent kinase inhibitor p27, a dosage-dependent tumor suppressor protein. In this study, we examined Skp2 and p27 protein expression by immunohistochemistry in normal oral epithelium and in different stages of malignant oral cancer progression, including dysplasia and oral squamous cell carcinoma. We found that increased levels of Skp2 protein are associated with reduced p27 in a subset of oral epithelial dysplasias and carcinomas compared with normal epithelial controls. Tumors with high Skp2 (>20% positive cells) expression invariably showed reduced or absent p27 and tumors with high p27 (>20% positive cells) expression rarely showed Skp2 positivity. Increased Skp2 protein levels were not always correlated with increased cell proliferation (assayed by Ki-67 staining), suggesting that alterations of Skp2 may contribute to the malignant phenotype without affecting proliferation. Skp2 protein overexpression may lead to accelerated p27 proteolysis and contribute to malignant progression from dysplasia to oral epithelial carcinoma. Moreover, we also demonstrate that Skp2 has oncogenic potential by showing that Skp2 cooperates with H-RasG12V to malignantly transform primary rodent fibroblasts as scored by colony formation in soft agar and tumor formation in nude mice. The observations that Skp2 can mediate transformation and is up-regulated during oral epithelial carcinogenesis support a role for Skp2 as a protooncogene in human tumors.

UR - http://www.scopus.com/inward/record.url?scp=0035942224&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035942224&partnerID=8YFLogxK

U2 - 10.1073/pnas.081474898

DO - 10.1073/pnas.081474898

M3 - Article

C2 - 11309491

AN - SCOPUS:0035942224

VL - 98

SP - 5043

EP - 5048

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 9

ER -